La Jolla Pharmaceutical Mergers and Acquisitions Summary

Life ScienceCompany

La Jolla Pharmaceutical has acquired 2 companies, including 1 in the last 5 years.

La Jolla Pharmaceutical’s largest acquisition to date was in 2020, when it acquired Tetraphase Pharmaceuticals for $43M. La Jolla Pharmaceutical has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).

Join Mergr and gain access to La Jolla Pharmaceutical’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 1

La Jolla Pharmaceutical

La Jolla Pharmaceutical Co.

4747 Executive Drive Suite 240,
San Diego, California 92121
United States,
(858) 207-4264

La Jolla Pharmaceutical is a biotechnology company involved in the development of therapeutics for lupus nephritis and other autoimmune diseases. La Jolla Pharmaceutical was founded in 1989 and is based in San Diego, California.

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.2/yr) # 1 - - 1 - - 2
vol $43M $43M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Tetraphase Pharmaceuticals, Inc. 2020-06-24 43M USD Add-on Acquisition
Watertown, Massachusetts ·
Solana Therapeutics, Inc. 2012-01-19 - Add-on Acquisition
San Diego, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) 43M (100%) - -
Medical Products 1 (50%) - - -
Total 2 $43M - -

By Geo

State/Country Buy Value Sell Value
United States 2 43M - -
  Massachusetts 1 43M - -
  California 1 - - -
Total 2 $43M - -

Deal Values

buy # Total
< $100M 1 $43M
Largest Tetraphase Pharmaceuticals, Inc.
$43M (2020-06-24)

 Subscribe to unlock this and 178,462
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.3K Private Equity Firms
  • 168K M&A Transactions
  • 174K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.